Also, studies have sought to predict the variability of T CD4 lymphocytes’ decrease in seropositive patients by determining the distribution of CD4 counts in seronegative patients and survival rates after acquiring HIV infection [12,13]. This evidence concerns the gene CD4 and HIV infectious disease.